Pharmaceutical Manufacturing & Packaging Market Reports

Manufacturing and packaging are high-interest areas in pharmaceuticals because these processes can adjust a product's safety, business success and profit margin.  With differences between some pharmaceutical products a matter of branding or marketing, the packaging of pharmaceuticals can be an important consideration in the product.  Unique products such as biopharmaceuticals require special packaging.  This group of market reports delivers insights into market analysis, competitive moves, trends, forecasting and benchmarking.  Reports on biopharmaceutical production, vaccine production, early toxicology, cell culture and other markets can be found in this section.  

loading... Loading...
Published: | Price: {{result.PriceString}}
...

No reports match your search criteria.


RSS Subscription
{{ pageDetailsDisplay }}
Published: May 18, 2016 | Price: $0.00
This White Paper, Offshoring Contract Research Activities, provides insight into three regions of the world where CROs are assisting pharmaceutical companies in drug discovery activities.  More information can be obtained in Kalorama Information's complete report on the subject, Outsourcing in Drug...
Published: Apr 30, 2014 | Price: $3,995.00
For six editions, this authoritative resource has defined the market opportunity for companies assisting in the beginning phase of the drug development process.This Kalorama Information Report, Outsourcing in Drug Discovery, t provides an in depth look into the trends that have shaped the drug...
Published: Jun 13, 2013 | Price: $2,500.00
In recent years, there has been a substantial increase in the number of drugs available to treat rare ("orphan") diseases. This comprehensive report, The World Market for Orphan Drugs, looks at this trend and provides estimates for the market opportunity in the U.S., Europe, Japan and globally. ...
Published: Sep 12, 2012 | Price: $3,995.00
Early toxicology testing is emerging as one of the mostsignificant areas of drug discovery. Toxicity is no longer something that can be left to the development stage, or just a small part of ADMET. Toxicity determinations are an integral part of all aspects of drug discovery & development. This...
Published: May 11, 2012 | Price: $3,995.00
The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, a molecule that affects biological function by binding to a target protein or nucleic acid in a way that is useful for treatment of disease. The...
Published: May 7, 2012 | Price: $3,995.00
Over-the-counter (OTC), non-legend, and non-prescription are all adjectives describing drugs that an individual may purchase without a prescription.  Many pharmaceutical companies seeking more revenue and international exposure have found an opportunity in the development of over-the-counter (OTC)...
Published: Feb 1, 2012 | Price: $2,500.00
Vaccines are among the top revenue earners in recent years, and in some cases have assisted major pharmaceutical companies to revenue growth. But this is not without some trade-offs. Vaccines involve a complex production process. Is vaccine-making profitable? How much is the industry spending? ...
Published: Feb 1, 2012 | Price: $3,800.00
This Kalorama Information report – The World Market for Anti-Infectives - focuses on three key segments of treatment: Antifungals (Allylamines, Azoles, Polyene Macrolides, Other Antifungals) Antibacterials (Aminoglycosides, Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones,...
Published: Dec 1, 2011 | Price: $500.00
Kalorama Information reports on a wide range of topics related to healthcare industry markets in the United States. This report, The Kalorama U.S.Pharmaceutical, Medical Device, Diagnostics Markets provides a broad look at the healthcare system and a summary of the market for the healthcare...
Published: May 1, 2011 | Price: $2,995.00
The future of the pharmaceutical market will be determined by biologics - drugs produced by natural organisms or recombinant techniques consisting of proteins and other products derived from living organisms for the treatment or management of diseases or injuries. What are the products that lead...
Published: Feb 1, 2011 | Price: $3,500.00
While many areas of the pharmaceutical industry will suffer from current economic conditions worldwide, sales of over-the-counter drugs are widely anticipated to grow as consumers seek cheaper alternatives. Manufacturers are expected to switch prescription drugs to over-the-counter status where...
Published: Jun 1, 2010 | Price: $3,995.00
Kalorama Information's Outsourcing in Drug Discovery offers unparalleled discussion of the drug discovery outsourcing market. It presents viewpoints from both customers and suppliers. Segments, size, and growth of the market are presented. The trend toward the increased use of offshore...
Published: May 1, 2010 | Price: $3,995.00
Over-the-Counter (OTC) drugs are non-prescription drugs sold to consumers at pharmacies, convenience and grocery stores. These drugs include pain relievers, cough and cold remedies, sleeping aids, antifungals, and other products approved for use as a self-medication product. There has been a...
Published: May 1, 2010 | Price: $995.00
RFID offers various solutions for the main segments of the healthcare industry—hospitals and nursing homes, pharmaceutical manufacturers, distributors, and pharmacies. This Kalorama Information report, The Global Market for RFID in Healthcare , defines the market for RFID opportunities in the...
Published: Apr 1, 2010 | Price: $3,995.00
This Kalorama Information report - The World Anesthesia Drug Market - focuses on three primary segments of anesthesia: General Anesthesia Local Anesthesia Adjunctive Therapies in Anesthesia The report covers both currently marketed and late stage development anesthesia drugs in detail. ...
Published: May 1, 2009 | Price: $995.00
While many areas of the pharmaceutical industry will suffer from current economic conditions worldwide, sales of over the counter drugs are widely anticipated to grow as consumers seek cheaper alternatives. Manufacturers are expected to switch prescription drugs to over the counter status where...
Published: Apr 1, 2009 | Price: $995.00
The pharmaceutical market in India ranks among the top twenty markets in the world with the potential to move up in ranking rather quickly. This market will be essential for pharmaceutical companies exploring new opportunities for growth. Developing regions will be an integral part of expansion...
Published: Jan 1, 2009 | Price: $995.00
This report is focused on two expanding pharmaceutical outsourcing markets, contract manufacturing of prescription drugs and contract sales and marketing. Both markets represent excellent post launch outsourcing opportunities for companies competing in this fast growing pharmaceutical outsourcing...
Published: Jan 1, 2009 | Price: $995.00
The pharmaceutical market in Russia ranks among the top twenty markets in the world with the potential to move up in ranking rather quickly. This market will be one of several that major pharmaceutical companies are exploring for new opportunities for growth. Reliance on commodity prices makes...
Published: Nov 1, 2008 | Price: $995.00
At present the Middle East region constitutes as small percent of global pharmaceutical sales. However, ever-increasing populations and governmental healthcare reforms are likely to increase demand. These markets will be essential for pharmaceuticals companies exploring new opportunities for...
Published: Oct 1, 2008 | Price: $7,995.00
According to Kalorama's experts, there is over a 40 billion dollar market for technology companies who can assist the healthcare industry meet its key challenges. This Kalorama Information Market Research Bundle, a combination of 7 Kalorama Information Market research reports - over 1200 pages of...
Published: Jul 1, 2008 | Price: $500.00
Pharmaceutical markets in Brazil, Russia, India and China rank among the top twenty markets in the world with the potential to move up in ranking rather quickly. (China’s pharmaceutical market, for instance, is expected to show double-digit growth over the next five years.) Developing...
Published: May 1, 2008 | Price: $995.00
Over-the-counter (OTC) drugs are well situated to capitalize on worldwide economic conditions. Customers in the US and in the world under time constraints and tight budgets prefer OTC and are opting to self-medicate where possible. Developing and petro-rich nations are pushing world demand for...
Published: May 1, 2008 | Price: $3,500.00
2008 has seen no decrease in the opportunities available for outsourcing drug discovery, for a number of reasons. New technologies increase the number of targets and accelerate the identification of active compounds. There is increasing pressure to develop new lead compounds due to the near-term...
Published: Apr 1, 2008 | Price: $500.00
Lagging FDA approvals led to a brief absence of Rx to OTC switches in the pharmaceutical marketplace, but 2006 and 2007 saw a number of switches, and Kalorama Information believes this product management tactic will continue to be aggressively utilized as companies seek ways to extend revenue life....
Published: | Price: {{result.PriceString}}
...
{{ pageDetailsDisplay }}

No reports match your search criteria.